Boots haemorrhoid relief (allantoin_lidocaine hydrochloride)

  • Home
  • Medicine
  • Boots haemorrhoid relief (allantoin_lidocaine hydrochloride)

Boots haemorrhoid relief (allantoin_lidocaine hydrochloride) Medicine

Overdose

Accidental ingestion may result in anaesthesia of the upper respiratory tract, nausea, vomiting and abdominal discomfort. Ingestion of very large quantities could result in CNS and cardiovascular toxicity.

Treatment should be symptomatic and supportive.

Contraindications

Hypersensitivity to any of the ingredients, especially lidocaine.

Incompatibilities

Not applicable

Undesirable effects

Hypersensitivity to any of the ingredients, particularly lidocaine. Occasionally may cause diarrhoea.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

Preclinical safety data

There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.

Therapeutic indications

For the symptomatic relief of pain and irritation associated with haemorrhoids.

Pharmacodynamic properties

C05A D0l - Products containing local anaesthetics

Lidocaine has a local anaesthetic action, relieving pain and discomfort in the affected areas. Allantoin is claimed to promote healing.

Pharmacokinetic properties

Not applicable

Name of the medicinal product

Boots Haemorrhoid Relief (Allantoin_Lidocaine hydrochloride)

Qualitative and quantitative composition

Allantoin; Lidocaine Hydrochloride

Special warnings and precautions for use

Boots Haemorrhoid Relief (Allantoin_Lidocaine hydrochloride) Suppositories/Tesco Haemorrhoid Relief Suppositories / Boots Haemorrhoid Suppositories / Care Haemorrhoid Relief Suppositories/Sainsburys Haemorrhoid Relief Suppositories are intended for use for short periods and should not be used for longer than 7 days without medical advice. Patients should be instructed to seek medical advice if they experience persistent pain or bleeding from the anus, especially where associated with a change in bowel habit, if the stomach is distended or if they are losing weight.

The label will state:

Keep all medicines out of the reach and sight of children.

If symptoms persist for more than 7 days consult your doctor.

Effects on ability to drive and use machines

No or negligible influence.

Dosage (Posology) and method of administration

Route of administration: For rectal administration.

Adults and the elderly.

If necessary empty the bowels before using the suppository. Remove the protective film and insert the suppository as deep as possible into the rectum. One suppository should be inserted night and morning after each bowel movement. Do not use for more than 7 days unless advised by your doctor.

Children.

Not recommended for children.

Special precautions for disposal and other handling

None stated.